Timothy S. Anderson, MD
Credit: University of Pittsburgh
An analysis of preventive aspirin trends by atherosclerotic cardiovascular disease (ASCVD) risk revealed that self-reported primary prevention aspirin use decreased among older adults and adults with low ASCVD risk, but additionally among adults with higher ASCVD risk.1
Evidence-based recommendations released by the American College of Cardiology/American Heart Association (ACC/AHA) in 2019 narrowed the patient population for preventive aspirin use to those at higher ASCVD risk and ≤70 years old without increased bleeding risk.2
“These findings build on a study through 2021 that did not examine trends by ASCVD risk,” wrote the investigative team, led by Timothy S. Anderson, MD, division of general internal medicine, University of Pittsburgh.1 “Further…